Stock Markets May 8, 2026 04:13 PM

Quantinuum Files S-1 for Nasdaq IPO, Sets Ticker as QNT

Quantum computing firm files registration with SEC; listing plans, bankers and global footprint detailed in filing

By Ajmal Hussain HON

Quantinuum has submitted a registration statement on Form S-1 with the U.S. Securities and Exchange Commission for a proposed initial public offering of its Class A common stock, according to a statement from Honeywell. The company intends to list on the Nasdaq Global Select Market under the ticker QNT. Key offering terms, including the number of shares and price range, remain undecided. Several investment banks have been named as book-running managers, and the registration has been filed but not yet become effective.

Quantinuum Files S-1 for Nasdaq IPO, Sets Ticker as QNT
HON

Key Points

  • Quantinuum filed a Form S-1 for a proposed IPO of Class A common stock, announced by Honeywell.
  • Planned Nasdaq Global Select Market listing under the ticker QNT; number of shares and price range not yet determined.
  • J.P. Morgan and Morgan Stanley named as joint lead active book-running managers; Jefferies and Evercore ISI also appointed. Industries cited include pharmaceuticals, material science, financial services, and government and industrial markets.

Quantinuum has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission for a proposed initial public offering of its Class A common stock, the company said in an announcement from Honeywell.

The company intends to have its Class A common stock listed on the Nasdaq Global Select Market under the ticker symbol "QNT." At this stage, the filing does not set the number of shares to be offered nor a price range for the potential sale.

J.P. Morgan and Morgan Stanley are named as joint lead active book-running managers for the offering. Jefferies and Evercore ISI are also listed as active book-running managers in the filing.

The registration statement has been submitted to the SEC but has not yet become effective. The filing emphasizes that the proposed offering is dependent on market conditions and notes there is no assurance about whether or when the offering may be completed, or what the actual size or terms might be.

In the registration, Quantinuum describes itself as a quantum computing company offering a full-stack platform intended for real-world deployment. The company lists its headquarters in Broomfield, Colorado, and discloses additional facilities across the United States, United Kingdom, Germany, Japan, and Singapore.

According to the filing, Quantinuum has active engagements with organizations spanning the pharmaceuticals, material science, financial services, and government and industrial markets.


Summary

Quantinuum has officially filed an S-1 registration statement for a proposed IPO of Class A common stock. The firm plans to list on the Nasdaq Global Select Market under the symbol QNT, though key offering details have yet to be determined. Major banks have been appointed to manage the book-running process. The filing remains subject to SEC effectiveness and market conditions.

Key points

  • Quantinuum filed a Form S-1 with the SEC for a proposed IPO of Class A common stock; the filing was announced by Honeywell.
  • The company plans to list on the Nasdaq Global Select Market under the ticker QNT, but the number of shares and pricing range are not yet set.
  • J.P. Morgan and Morgan Stanley are joint lead active book-running managers; Jefferies and Evercore ISI also serve as active book-running managers. Sectors cited in the filing that could be affected include pharmaceuticals, material science, financial services, and government and industrial markets.

Risks and uncertainties

  • The registration statement has been filed but is not yet effective, so the offering cannot proceed until effectiveness is achieved.
  • The proposed offering is subject to market conditions; there is no assurance the offering will be completed or that its timing, size, or terms will match current plans.
  • Specifics about the offering - including the share count and price range - remain undetermined, creating uncertainty for potential investors in related sectors such as financial services and industrial markets.

Risks

  • The registration statement has been filed but is not yet effective, so the offering cannot proceed until clearance is granted - impacting timing for market participants.
  • The proposed offering is subject to market conditions and the filing states there is no assurance that the offering will be completed or when it may occur - creating execution risk for investors.
  • Key terms of the offering, including the number of shares and the price range, have not been determined, introducing uncertainty for sectors tied to the company's engagements such as pharmaceuticals and financial services.

More from Stock Markets

Nvidia CEO Jensen Huang Sees 27% Drop in Total Pay as Stock Awards Lose Value May 12, 2026 Activist Urges BWX Technologies to Revisit Shelved Reactor Plan, Sees Potential for Stock to Double May 12, 2026 S&P Moves Mexico’s Outlook to Negative, Citing Fiscal Strain and Tepid Growth May 12, 2026 Moody's Lowers Everforth Outlook to Negative Amid Elevated Leverage May 12, 2026 Moody's Moves Albemarle Outlook to Stable After Debt Cuts and Stronger Lithium Prices May 12, 2026